Using trained dogs to detect tumors in suspected cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the ability of trained sniff dogs to identify cancer patients by analyzing their exhaled breath, blood, serum, urine, or feces. The dogs will sniff serum samples from participants who are suspected of having tumors based on their physicians' evaluations but have not yet received a pathological diagnosis. The results from the dogs' assessments will be compared to the outcomes of subsequent pathological examinations to determine the accuracy of this method in identifying neoplasia.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Healthy volunteers who have been examined by the currently used procedures and find to be without tumors.
* Patients in the breast surgery, thoracic surgery, gynecological and neurosurgery departments with lesions with characteristics of tumors

Exclusion Criteria:

* Patients who have had pathological results

Where it's running

• Center for Scientific Research with Animal Models, CSU
  Changsha, Hunan, China Recruiting

Study contacts

• Principal investigator: Chang-Qing Gao, MD PhD — Central South University
• Study coordinator: Chang-Qing Gao, MD PhD
• Email: cgao851@126.com
• Phone: 86 188 7486 9488

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using REMS ultrasound to check bone density in children and teens with conditions that lower bone strength

  This project will test whether REMS, a radiation-free ultrasound method, can measure bone mineral density in children and adolescents aged 5–18 who have conditions that weaken their bones.

  Recruiting Meyer Children's Hospital IRCCS · Florence, Tuscany · NCT07412782

• ProTarget — Danish nationwide targeted cancer treatment based on genomic profiling

  This study will try commercially available targeted cancer medicines chosen for adults with advanced cancer based on specific DNA or protein changes in their tumor.

  Recruiting Phase 2 Copenhagen University Hospital, Rigshospitalet · Aalborg, Aalborg and 6 other locations · NCT04341181

• Access to targeted cancer therapies based on tumor genetics

  This study is testing if matching advanced cancer patients with targeted treatments based on their tumor genetics can improve their outcomes and make it easier for them to access these therapies.

  Recruiting at 34 sites Phase 2 The Netherlands Cancer Institute · Alkmaar and 35 other locations · NCT02925234

• Registry and biosample collection for cancer patients undergoing radiotherapy

  This study is collecting blood, urine, and tumor samples from cancer patients receiving radiotherapy to see how the treatment affects them and to help improve future care.

  Recruiting at 3 sites Abramson Cancer Center at Penn Medicine · Moorestown, New Jersey and 3 other locations · NCT01577251

• Point-of-care triage and thermal treatment for cervical precancer with the IRIS device

  This project tests a portable thermal ablation device plus an AI image triage tool to treat and prioritize HPV-positive women aged 30–49 with cervical precancer in El Salvador.

  Recruiting Basic Health International, Inc. · San Salvador, San Salvador Department · NCT07461818

• HPV self-sampling to improve cervical screening for women in Zaporizhzhia during the war

  This project will test whether giving women aged 30–60 in Zaporizhzhia HPV self-sampling kits can keep cervical screening going when clinic access is disrupted by the war.

  Recruiting Karolinska Institutet · Zaporizhzhya · NCT07275333

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.